Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dilutive issuance
confidence 95%
filed 2026-09-23
Item 3.02
Blue Owl Credit Income Corp. completed an unregistered private placement of 191,466 shares of Class I common stock for $1.75 million, exempt under Section 4(a)(2) and Regulation S. This equity issuance dilutes existing shareholders and represents a material capital raise affecting the registrant's capitalization structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-23
Item 3.02
Blue Owl Technology Income Corp. completed an unregistered sale of 89,128 shares of Class I common stock to feeder vehicles as of September 1, 2026, exempt under Section 4(a)(2) and Regulation S.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-23
Item 3.02
The filing discloses an unregistered sale of equity securities totaling approximately $205.3 million across three share classes (Class I-Series 1, Class S, and Class D) to investors for cash on September 1, 2026. The sale was exempt under Section 4(a)(2) and Regulations D and S, which are hallmarks of private placements. The company notes it has raised approximately $7.979 billion since inception through such continuous private offerings, indicating material capital-raising activity that dilutes existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-23
Item 3.02
The filing discloses an unregistered sale of equity securities totaling approximately $268.2 million across multiple share classes (Class I-Series 1, Class U, Class D, and Class S Shares) to investors on September 1, 2026, exempt under Section 4(a)(2) and Regulations D and S. This is a classic dilutive private placement by a private equity fund vehicle, and the magnitude ($268M in a single transaction, $10.9B cumulatively since inception) is material to investors assessing the registrant's capital structure and ownership dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Willis Lease Finance Corporation entered into a private placement agreement to issue 1,750,000 shares of Series B Preferred Stock at $20.00 per share for approximately $35 million in gross proceeds. The securities are unregistered and issued in reliance on Section 4(a)(2) of the Securities Act, which is the classic private placement exemption. This is a material capital raise that dilutes existing shareholders and represents a significant financing event for the company.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-09-22
EX-99.1
Canagold closed a $7.1 million private placement consisting of 5.3 million common shares at $0.47 and 8.8 million flow-through shares at $0.52. This is a dilutive equity issuance on a private placement basis. The transaction is material: it raises significant capital, increases share count substantially, and notably increases insider Sun Valley's ownership from 48.25% to 49.75%, triggering MI 61-101 related-party transaction disclosure requirements.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-22
RTB Digital entered into Securities Purchase Agreements on September 16 and 22, 2026, for the unregistered sale of 494,159 shares of common stock at $11.13 per share for gross proceeds of $5,500,000 under Regulation 506(b). The shares are restricted and subject to lock-up agreements releasing in four tranches through February 2028. This is a classic private placement (PIPE-like) dilutive issuance of unregistered equity securities, disclosed under Item 3.02, with material capital-raising implications for the registrant.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Vista Credit Strategic Lending Corp. completed an unregistered sale of 124,395.879 shares of Class I common stock for $2,396,300 to accredited investors and non-U.S. persons, relying on Section 4(a)(2) and Regulation D/S exemptions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-09-22
Item 8.01
LeonaBio disclosed the exercise of Series A Common Warrants issued in a December 2025 private placement, covering 23,031,494 shares with an exercise price of $6.35 per share. The warrants became exercisable on September 18, 2026, and represent a potential $146.2 million capital raise if fully exercised. This is a dilutive equity issuance tied to a prior private placement, material to investors assessing capital structure and shareholder dilution risk.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 1.01
Alaunos Therapeutics entered into a securities purchase agreement on September 18, 2026, to sell 380,469 shares of common stock and 386,654 pre-funded warrants at $1.46 per share in a registered direct offering, raising approximately $915,400 to $1.1 million in proceeds for general corporate purposes.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Apollo Debt Solutions BDC sold 357,105 unregistered Class I Common Shares for $8.5 million to feeder vehicles, relying on Section 4(a)(2) and Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Fortress Private Lending Fund sold 1,065,109 Class I common shares for $25.8 million in aggregate consideration to accredited investors pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Simultaneously with the IPO closing, Haymaker sold 5,333,333 unregistered warrants to the Sponsor and Underwriters at $1.50 per warrant ($8.0 million aggregate) pursuant to Section 4(a)(2) exemption, exercisable for Class A ordinary shares at $11.50 per share. This private placement represents a material dilutive issuance of equity securities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Goldman Sachs Private Credit Corp. completed an unregistered sale of approximately $94 million in Class I and Class S shares to accredited investors and non-U.S. persons, exempt under Section 4(a)(2), Regulation D, and Regulation S.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-22
Item 1.01
Elmet Group entered into a warrant purchase agreement with Blue Moon Metals Inc. to issue unregistered warrants to purchase up to 1,166,970 shares of common stock at $21.423 per share under a three-year term with cashless exercise provisions. The unregistered warrant issuance is a private placement under Section 4(a)(2) of the Securities Act that will result in material dilution to existing shareholders upon exercise.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
SCWorx entered into a Securities Purchase Agreement on September 16, 2026, to issue 350,000 shares of common stock and 350,000 warrants to ten accredited investors in a private placement for $938,000 in gross proceeds. The filing explicitly discloses this under Item 3.02 (Unregistered Sales of Equity Securities) as a Section 4(a)(2) private placement. The company also issued 49,860 fee shares to the placement agent Dawson James. This is a classic dilutive equity issuance raising capital through unregistered securities.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-09-22
The Company entered into a Share Purchase Agreement on September 22, 2026 to sell and issue up to 665,000 Class A ordinary shares at US$3.00 per share in a registered direct offering. This is a direct equity issuance that will dilute existing shareholders and represents a material capital-raising event for the registrant.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-22
The filing discloses entry into a distribution agreement on September 22, 2026, for an "at the market" offering of up to 2,500,000 shares of common stock through PINE Distributors LLC and UBS Securities LLC as sub-placement agent. This is a registered direct equity issuance under an effective shelf registration statement (Form N-2/ASR), representing a dilutive capital raise that would materially affect existing shareholders and the company's capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
The filing discloses a private placement of 123,650 shares of common stock at $8.50 per share for $1,051,025 in gross proceeds, plus 100% warrant coverage (123,650 warrants at $8.50 exercise price). The securities were offered and sold pursuant to Section 4(a)(2) and Rule 506 exemptions from registration (Item 3.02), and the transaction is structured as an unregistered equity issuance with significant dilution potential. The press release emphasizes this as a premium-priced private placement from returning investors, representing material capital raising activity typical of dilutive issuances at small- and mid-cap companies.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-09-22
EX-99.1
RedCloud announced a private placement of 74,000 unregistered ordinary shares to CEO Justin Floyd at $2.50 per share ($185,000 aggregate), paid via offset of liabilities owed to Mr. Floyd. This is an unregistered equity issuance that dilutes existing shareholders and represents a material capital transaction, particularly given the substantial premium to market price and the CEO's involvement. The structure (set-off agreement offsetting liabilities) and unregistered nature align with the dilutive_issuance category.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
The filing discloses a registered direct offering of 1,025,640 shares of common stock at $1.17 per share, generating approximately $1.2 million in gross proceeds. Item 1.01 explicitly describes entry into a stock purchase agreement with accredited investors and qualified institutional buyers for this direct equity issuance. This is a classic dilutive equity capital raise that would materially affect shareholder ownership and is disclosed under Item 1.01 as a material definitive agreement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-22
The filing discloses an amendment to an At Market Issuance Sales Agreement (ATM offering) increasing the maximum aggregate amount of common stock issuable to an additional $6,076,872. This is a dilutive equity issuance under a registered offering, which materially affects shareholder equity and voting power. The company is updating its prospectus supplement to expand the authorized amount of shares available for sale under the existing ATM facility.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-22
Item 3.02
The Fund sold 297,543 Class I common shares for $8.0 million in an unregistered offering exempt under Section 4(a)(2) and Regulation S, materially diluting existing shareholders' ownership percentages.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
HPS Corporate Capital Solutions Fund disclosed an unregistered sale of approximately $18.31 million in common shares of beneficial interest across Class I and Class D shares, sold pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulations D and S.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
This Item 3.02 disclosure describes an unregistered private placement of preferred stock to accredited investors under Regulation D Rule 506(b). The Company issued 211,102 shares of Series 2025 Preferred Stock during the period, receiving $2,055,000 in aggregate proceeds. As of the filing date, 12,708,673 shares of this series were outstanding, representing a material dilutive equity issuance that would affect investor assessment of capital structure and ownership.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Blackstone Private Credit Fund completed an unregistered sale of 150,127 Class I common shares for $3,543,000 pursuant to Section 4(a)(2) and Regulation S, representing a private placement that dilutes existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-09-22
Item 8.01
Circle issued 1,237,011 shares of Class A common stock to Binance in a private placement for $100 million at $80.84 per share, representing a discount to market price. This is a material dilutive equity issuance exempt from registration under the Securities Act. While the filing also discloses a commercial arrangement expansion, the principal disclosed action is the private placement of equity securities, which is the hallmark of dilutive_issuance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Ares Core Infrastructure Fund sold 31,031,335 Common Shares across four classes for an aggregate purchase price of $769.0 million in an unregistered offering exempt under Section 4(a)(2) and Regulation D (Rule 506(b)).
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Blackstone Multi-Strategy Hedge Fund L.P. sold approximately $67.0 million in unregistered limited partnership units to accredited investors and qualified purchasers under Section 4(a)(2) and Regulation D, representing a significant capital raise and dilution to existing unitholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-09-21
Item 8.01
The Company filed a prospectus supplement to increase the maximum number of shares issuable under an At The Market (ATM) offering agreement with H.C. Wainwright & Co. This represents an expansion of the Company's capacity to issue equity securities on a dilutive basis. ATM offerings are a classic signal of equity financing activity at smaller-cap issuers, and the increase in authorized issuance capacity is material to existing shareholders' interests.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-21
Item 3.02
Stone Point Credit Income Fund issued 498,046.412 common shares at NAV of $24.6901 for aggregate proceeds of $12.3 million pursuant to subscription agreements with accredited investors under Section 4(a)(2) and Regulation D Rule 506. This is a classic unregistered private placement of equity securities, explicitly disclosed under Item 3.02, with material capital raised and significant unfunded commitments ($776.5M) remaining.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-21
Item 8.01
Soligenix increased the maximum aggregate offering amount under its At Market Issuance Sales Agreement (ATM offering) by an additional $2,500,000 of common stock, with approximately $6,234,000 already sold under prior prospectus supplements.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 90%
filed 2026-09-21
Item 1.01
On September 21, 2026, abrdn Global Infrastructure Income Fund entered into a dealer manager agreement and commenced a rights offering of up to 10,545,755 transferable subscription rights to existing shareholders, entitling them to purchase new common shares at a specified subscription price (1 new share for every 3 rights held). This material capital-raising activity dilutes existing shareholders' ownership unless they participate proportionally.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 93%
filed 2026-09-21
Item 1.01
Magnachip entered into a Stock Purchase Agreement with Navitas Semiconductor to issue 1,461,988 shares of common stock at $3.42 per share for $5 million in aggregate proceeds. The shares are unregistered, issued in reliance on Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, representing a material private placement that dilutes existing shareholders and raises capital.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-21
Item 3.02
AB Private Lending Fund sold 2,057 unregistered Class I common shares to feeder vehicles on September 1, 2026, pursuant to Section 4(a)(2) and Regulation S exemptions, expanding the Fund's equity base and diluting existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-09-21
Item 8.01
The filing discloses an ongoing private placement offering of up to $2.165 billion of common shares across multiple classes, with $546.749 million raised as of August 31, 2026. This represents a material dilutive issuance of equity securities. While the disclosure also mentions dividend declarations and DRIP activity, the primary focus of the Item 8.01 section is the status and scale of the continuous private offering, which is a classic dilutive equity issuance event material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-21
Item 3.02
PennantPark Private Income Fund completed an unregistered sale of 32,047 common shares for approximately $830,000 to accredited investors pursuant to Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-21
Item 1.01
Generation Income Properties entered into a warrant inducement agreement whereby an investor exercised existing warrants for approximately $4.3 million in gross proceeds and received unregistered "Reload Warrants" to purchase 8,148,718 additional shares at $1.05 per share (representing 200% of the exercised warrants). This private placement of unregistered securities under Section 4(a)(2) materially increases shareholder dilution and is contingent on stockholder approval.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-09-21
EX-99.1
Tokyo Lifestyle Co., Ltd. announced a third-party allotment of 13,503,648 common shares (1,396,755 shares for cash + 12,106,893 shares via debt-to-equity swap) totaling approximately JPY 568.8 million. The debt-to-equity swap component converts JPY 510 million in subordinated loan receivables held by TOKUSHIN G.K. into equity, which is a classic dilutive issuance structure. This materially increases share count and dilutes existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-09-21
Item 3.02
The Company issued unregistered equity units convertible from the promissory notes issued to Daniel Fetters and Edward King, representing a dilutive equity issuance as part of the financing transaction.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-21
Item 1.01
AIAI Holdings entered into a Common Stock Purchase Agreement with B. Riley Principal Capital II granting the Company the right to sell up to $200 million of newly issued Class A common stock over 36 months under an at-the-market arrangement, subject to an Exchange Cap limitation of 14,125,485 shares (19.99% of outstanding), representing material potential dilution to existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-09-21
InspireMD amended existing Series J and Series K warrants on September 21, 2026, modifying exercise prices and termination dates to align with anticipated FDA approval of CGuard Prime 80 cm. The amendments cover approximately 4.8 million Series J shares and 9.5 million Series K shares, with potential gross proceeds of up to $11 million if exercised. While technically an amendment to existing warrants rather than a new issuance, the modification materially enhances the likelihood and timing of exercise, effectively functioning as a dilutive capital-raising mechanism tied to a near-term regulatory milestone.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-09-21
DSS entered into a securities purchase agreement with Alset Inc. on September 15, 2026, receiving a $500,000 loan in exchange for a convertible promissory note convertible at $0.50/share and 8,000,000 warrants exercisable at $0.55/share. This is a dilutive issuance of equity securities (convertible debt and warrants) in exchange for capital, requiring stockholder approval. While the transaction also involves debt issuance, the primary material event is the significant dilutive equity component and warrant issuance to a related party.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-21
GT Biopharma disclosed a private placement of Series M Convertible Preferred Stock and warrants under Item 1.01 and Item 3.02 (Unregistered Sales of Equity Securities). The company issued 8,611.111 shares of preferred stock convertible into common stock, plus warrants equal to 100% of conversion shares, for $7.75 million in aggregate purchase price. This is a classic dilutive equity issuance raising capital through unregistered securities, with additional dilution from the Greenshoe Rights option for up to $31.2 million more. The filing explicitly references Rule 506(b) of Regulation D, confirming the private placement nature.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-21
Item 1.01
Host Digital Inc. completed a registered public offering of 2,187,500 shares of Class A common stock at $8.00 per share, generating approximately $17.5 million in gross proceeds, with underwriters granted a 30-day overallotment option for an additional 328,125 shares. The proceeds are designated for data center investments and general corporate purposes.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-09-21
EX-99.1
This exhibit announces a registered direct offering of 23,809,530 Ordinary Shares (or pre-funded warrants) at $0.21 per share, together with Series A and Series B warrants, for gross proceeds of approximately $5.0 million. The offering involves significant equity dilution through both ordinary shares and multiple warrant tranches exercisable at lower prices ($0.44 for Series A, $0.21 for Series B), which is characteristic of a dilutive equity issuance. The company explicitly states the securities are being offered pursuant to a shelf registration statement on Form F-3, confirming this is a registered direct offering—a material capital-raising event that would affect investor assessment of ownership dilution and the company's financial position.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-21
Item 3.02
Ares Sports, Media & Entertainment Opportunities LP completed an unregistered private placement of limited partnership units totaling approximately $47.0 million to accredited investors and qualified purchasers under Section 4(a)(2) and Regulation D. This brings the Fund's aggregate issued interests to approximately $911 million.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-09-21
EX-99.18
CordovaCann completed a non-brokered private placement of 6,718,000 units (each comprising one common share and one warrant) at $0.25 USD per unit for gross proceeds of $1,679,500 USD on April 20, 2022. Tom Bushey, founder and CEO of lead investor Sunderland Capital, was appointed to the Board of Directors.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-09-21
EX-99.22
CordovaCann completed a non-brokered private placement on August 18, 2021, issuing 3,379,379 units (each comprising one common share and one warrant) at $0.30 per unit for gross proceeds of $1,013,814. Director Jakob Ripshtein subscribed for 325,000 units, increasing his ownership from 1,400,000 to 1,725,000 shares.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-09-21
EX-99.27
CordovaCann closed a non-brokered private placement issuing 6,177,718 common shares at $0.32 per share for gross proceeds of $1,976,870. The securities were not registered under the Securities Act of 1933 and are subject to a four-month hold period.
View raw filing on EDGAR →